Elizabeth Leary

1.9k total citations · 1 hit paper
34 papers, 1.4k citations indexed

About

Elizabeth Leary is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Elizabeth Leary has authored 34 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 17 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Cancer Research. Recurrent topics in Elizabeth Leary's work include Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Lipoproteins and Cardiovascular Health (14 papers) and Cancer, Lipids, and Metabolism (7 papers). Elizabeth Leary is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Lipoproteins and Cardiovascular Health (14 papers) and Cancer, Lipids, and Metabolism (7 papers). Elizabeth Leary collaborates with scholars based in United States, Japan and United Kingdom. Elizabeth Leary's co-authors include G. Russell Warnick, Mary M. Kimberly, Katsuyuki Nakajima, Richard Eastell, Nicholas R Hoyle, Paweł Szulc, K.E. Naylor, Gary L. Myers, Tracey McLaughlin and Cindy Lamendola and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Arteriosclerosis Thrombosis and Vascular Biology and The American Journal of Cardiology.

In The Last Decade

Elizabeth Leary

30 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability

2017 231 citations Paweł Szulc, K.E. Naylor et al. Osteoporosis International profile →

Peers

Countries citing papers authored by Elizabeth Leary

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Leary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Leary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Leary more than expected).

Fields of papers citing papers by Elizabeth Leary

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Leary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Leary. The network helps show where Elizabeth Leary may publish in the future.

Co-authorship network of co-authors of Elizabeth Leary

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Leary. A scholar is included among the top collaborators of Elizabeth Leary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Leary. Elizabeth Leary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	120 Using Implementation Science to Develop a TL1 D&I Science Training Implementation Plan – ADDENDUM 2023 ·Journal of Clinical and Translational Science ·Denise H. Daudelin, (unknown), (unknown), Thomas W. Concannon, Robert Sege, Elizabeth Leary, Angie Mae Rodday	1
2	Impact of an accessory cavitated uterine mass on fertility: case presentation and review of the literature 2023 ·F&S Reports ·Michael Strug, (unknown), (unknown), Vivian Romero, (unknown), Elizabeth Leary, Mili Thakur	2
3	Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability 2018 ·Annales de biologie clinique ·Paweł Szulc, K.E. Naylor, (unknown), Nicholas R Hoyle, Richard Eastell, Elizabeth Leary	14
4	Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability breakdown → 2017 ·Osteoporosis International ·(unknown), Paweł Szulc, K.E. Naylor, Nicholas R Hoyle, Richard Eastell, Elizabeth Leary	231
5	A Phase 0 study of the inhibition of cholesteryl ester transfer protein activity by JNJ-28545595 in plasma from normolipidemic and dyslipidemic humans 2012 ·International Journal of Clinical Pharmacology and Therapeutics ·Troy C. Sarich, Margery A. Connelly, (unknown), Atalanta Ghosh, Prasarn Manitpisitkul, Elizabeth Leary, Paul Rothenberg, Keith T. Demarest, Bruce P. Damiano	3
6	Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib 2012 ·Journal of Lipid Research ·Michael H. Davidson, (unknown), Philip J. Barter, Eliot A. Brinton, Christopher P. Cannon, Antonio M. Gotto, Elizabeth Leary, Sukrut Shah, Michael Stepanavage, Yale Mitchel, Hayes M. Dansky	37
7	Abstract 502: CSL112, a Novel Formulation of Human ApoA-I, Enhances the Capacity of Serum to Efflux Cholesterol from Macrophages 2012 ·Arteriosclerosis Thrombosis and Vascular Biology ·Andreas Gille, (unknown), Elizabeth Leary, (unknown), Daniel J. Rader, Samuel D. Wright	1
8	Translation: Non-HDL Cholesterol Shows Improved Accuracy for Cardiovascular Risk Score Classification Compared to Direct or Calculated LDL Cholesterol in a Dyslipidemic Population 2011 ·Laboratory Medicine Online ·Hendrick E. van Deventer, W. Greg Miller, Gary L. Myers, Ikunosuke Sakurabayashi, Lorin M Bachmann, Samuel P. Caudill, (unknown), Selvin H. Edwards, Mary M. Kimberly, William J. Korzun, Elizabeth Leary, Katsuyuki Nakajima, Masakazu Nakamura, Robert D. Shamburek, George W. Vetrovec, G. Russell Warnick, Alan T. Remaley	1
9	Non–HDL Cholesterol Shows Improved Accuracy for Cardiovascular Risk Score Classification Compared to Direct or Calculated LDL Cholesterol in a Dyslipidemic Population 2011 ·Clinical Chemistry ·Hendrick E. van Deventer, W. Greg Miller, Gary L. Myers, Ikunosuke Sakurabayashi, Lorin M Bachmann, Samuel P. Caudill, (unknown), Selvin H. Edwards, Mary M. Kimberly, William J. Korzun, Elizabeth Leary, Katsuyuki Nakajima, Masakazu Nakamura, Robert D. Shamburek, George W. Vetrovec, G. Russell Warnick, Alan T. Remaley	87
10	Seven Direct Methods for Measuring HDL and LDL Cholesterol Compared with Ultracentrifugation Reference Measurement Procedures 2010 ·Clinical Chemistry ·W. Greg Miller, Gary L. Myers, Ikunosuke Sakurabayashi, Lorin M Bachmann, Samuel P. Caudill, (unknown), Selvin H. Edwards, Mary M. Kimberly, William J. Korzun, Elizabeth Leary, Katsuyuki Nakajima, Masakazu Nakamura, Göran Nilsson, Robert D. Shamburek, George W. Vetrovec, G. Russell Warnick, Alan T. Remaley	262
11	Pioglitazone decreases postprandial accumulation of remnant lipoproteins in insulin‐resistant smokers 2009 ·Diabetes Obesity and Metabolism ·Fahim Abbasi, Cindy Lamendola, Elizabeth Leary, Gerald M. Reaven	1
12	Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia 2005 ·The American Journal of Cardiology ·Cindy Lamendola, Fahim Abbasi, James W. Chu, Howard G. Hutchinson, Valerie A. Cain, Elizabeth Leary, Tracey McLaughlin, Evan A. Stein, Gerald M. Reaven	37
13	Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus 2004 ·Metabolism ·Fahim Abbasi, James W. Chu, Tracey McLaughlin, Cindy Lamendola, Elizabeth Leary, Gerald M. Reaven	130
14	Lipoprotein risk factors for cardiovascular disease in patients with type 2 diabetes mellitus treated with oral antihyperglycaemic agents 2003 ·Diabetes Obesity and Metabolism ·James W. Chu, Fahim Abbasi, Tracey McLaughlin, Cindy Lamendola, Patricia Schaaf, (unknown), Elizabeth Leary, Gerald M. Reaven	1
15	Comparison in patients with type 2 diabetes of fibric acid versus hepatic hydroxymethyl glutaryl-coenzyme a reductase inhibitor treatment of combined dyslipidemia 2002 ·Metabolism ·Tracey McLaughlin, Fahim Abbasi, Cindy Lamendola, Elizabeth Leary, Gerald M. Reaven	9
16	Ratio of remnant-like particle-cholesterol to serum total triglycerides is an effective alternative to ultracentrifugal and electrophoretic methods in the diagnosis of familial type III hyperlipoproteinemia. 1999 ·PubMed ·Tao Wang, Katsuyuki Nakajima, Elizabeth Leary, G. Russell Warnick, Jeffrey S. Cohn, P N Hopkins, Lianjun Wu, Donald D. Cilla, Judy Zhong, Richard J. Havel	38
17	Multicenter Evaluation of a Patient-Administered Test for Blood Cholesterol Measurement 1996 ·Preventive Medicine ·Judith McNamara, G. Russell Warnick, Elizabeth Leary, Ellison H. Wittels, (unknown), (unknown), Ernst J. Schaefer	4
18	Modification of the dextran-Mg2+ high-density lipoprotein cholesterol precipitation method for use with previously frozen plasma 1994 ·Clinical Chemistry ·Judith McNamara, (unknown), (unknown), Elizabeth Leary, G. Russell Warnick, (unknown), Sander J. Robins, Ernst J. Schaefer	34
19	Cholesterol in fingerstick capillary specimens can be equivalent to conventional venous measurements. 1994 ·PubMed ·G R Warnick, Elizabeth Leary, Enrico Ammirati, (unknown)	19
20	Proficiency testing for blood-gas quality control. 1976 ·Clinical Chemistry ·(unknown), Elizabeth Leary, Vidmantas A. Raisys, M A Kenny	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact